Form 4: Liquidia Corp's Chief Medical Officer Sells Shares to Cover Tax Obligations

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, sold shares of common stock on March 18, 2024, to cover tax obligations related to the settlement of restricted stock units.

Summary

• Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, filed a Form 4 disclosing changes in beneficial ownership.
• On March 18, 2024, Saggar sold 1,654 shares of Liquidia Corp common stock at a price of $15.82 per share to cover taxes associated with the settlement of restricted stock units (RSUs) granted on July 28, 2022.
• Additionally, Saggar sold 5,876 shares at the same price to cover taxes associated with the settlement of RSUs granted on January 11, 2023.
• Following these transactions, Saggar beneficially owns 214,846 shares of Liquidia Corp common stock, which includes unvested RSUs and shares acquired under the employee stock purchase plan.
• The sales were executed pursuant to a Rule 10b5-1 plan adopted on December 15, 2023.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales for tax purposes under a pre-arranged plan, without indicating any fundamental change in the company's prospects.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects. Rule 10b5-1 plans are frequently used to schedule such sales in advance, mitigating concerns about insider trading.

Stakeholder Impact

• The stock sales by the Chief Medical Officer could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares involved.

Key Dates